Evogene Evogene
Toggle navigation
  • Company
  • AI Tech-Engines
    • CPB Platform
  • Divisions
    • Drug Discovery
  • Licensing & Collaboration
  • ESG
    • Environmental
    • Social
    • Governance
  • News & Events
  • Investors
  • Careers
  • Contact

Financial Reports

  • Stock Data Stock Data
  • Financial Reports Financial Reports
  • Sec Filings Sec Filings
  • Press Releases Press Releases
  • Presentations and Webcasts Presentations and Webcasts
  • Analyst Coverage Analyst Coverage
  • Events Events
Back

Financial Reports

  • pdfQ2 2025 Consolidated Financial Statements
  • pdfQ1 2025 Consolidated Financial Statements
  • pdfAnnual report 2024 - 20-F
  • pdfQ4 2024 Consolidated Financial Statements
  • pdfQ3 2024 Consolidated Financial Statements
  • pdfOperating and Financial Review and Prospects_as of_and for the six month ended June 30 2024
  • pdfQ2 2024 Consolidated Financial Statements
  • pdfQ1 2024 Consolidated Financial Statements
  • pdf2024 Annual General Meeting of Shareholders
  • pdfAnnual Report 2023 - 20-F
  • pdfQ4 and Full Year 2023 Consolidated Financial Statements
  • pdfQ3 2023 Consolidated Financial Statements
  • pdfInterim Financial Statements and MD&A for the Six Months Ended June 30, 2023
  • pdfQ2 2023 Consolidated Financial Statements
  • pdfQ1 2023 Consolidated Financial Statements
  • pdfAnnual report 2022 - 20-F
  • pdfQ4 and Full Year 2022 Consolidated Financial Statements
  • pdfQ3 2022 Consolidated Financial Statements
  • pdfQ2 2022 Consolidated Financial Statements
  • pdfQ1 2022 Consolidated Financial Statements
  • pdf Annual report 2021 - 20-F
  • pdfQ4 2021 Consolidated Financial Statements
  • pdfQ3 2021 Consolidated Financial Statements
  • pdfQ2 2021 Consolidated Financial Statements
  • pdfQ1 2021 Consolidated Financial Statements
  • pdfAnnual report 2020 - 20-F
  • pdfQ3 2020 Consolidated Financial Statements
  • pdfQ2 2020 Consolidated Financial Statements
  • pdfQ1 2020 Consolidated Financial Statements
  • pdfAnnual report 2019 - 20-F
  • pdfQ4 2019 Consolidated Financial Statements
  • pdfQ3 2019 Consolidated Financial Statements
  • pdfQ2 2019 Consolidated Financial Statements
  • pdfQ1 2019 Consolidated Financial Statements


Evogene
  • Technology
  • AI Tech-Engines
    • MicroBoost AI
    • ChemPass AI
    • GeneRator AI
  • Press
    • Press releases
    • In the media
    • Webcast
  • Investor Relations
  • About Evogene

Contact us

13 Gad Feinstein st.,
Park Rehovot,
Rehovot 7638517, Israel

Tel: 972-8-9311900
Fax: 972-8-9466724
E-mail: info@evogene.com

Facebook icon Linkedin icon

Copyright © 2024 Evogene Ltd.
All Rights Reserved.



CONTACT US

    INVESTOR EMAIL ALERTS

    Sign Up for Investor Relations Email Alerts






      Privacy Policy   Terms of Use   Accessibility Statement

      Designed and built by Studio Praktik